Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abcellera, ABM, Alphamab, Ascletis, Beigene, Bharat, Biontech, Biotheus, Cybin, Eli Lilly, Eusa, Henlius, Iaso, Immunome, Jacobio, Janssen, Junshi, Legend, Merck, Mingmed, Nabriva, Ocugen, Pfizer, Pharmadrug, RDIF, Redhill, Roche, Tot, Tracon, Valneva.